Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021)

CollPlant Biotechnologies filings provide 4 years of Other Non Operating Income readings, the most recent being -$42.0 million for Q3 2021.

  • On a quarterly basis, Other Non Operating Income fell 110.0% to -$42.0 million in Q3 2021 year-over-year; TTM through Sep 2021 was -$49.8 million, a 155.85% decrease, with the full-year FY2020 number at $181000.0, down 21.3% from a year prior.
  • Other Non Operating Income hit -$42.0 million in Q3 2021 for CollPlant Biotechnologies, down from -$39000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $511000.0 in Q4 2019 to a low of -$42.0 million in Q3 2021.
  • Median Other Non Operating Income over the past 4 years was -$71500.0 (2018), compared with a mean of -$5.0 million.
  • Biggest five-year swings in Other Non Operating Income: soared 755.13% in 2019 and later crashed 51182.05% in 2020.
  • CollPlant Biotechnologies' Other Non Operating Income stood at -$78000.0 in 2018, then soared by 755.13% to $511000.0 in 2019, then crashed by 1630.14% to -$7.8 million in 2020, then tumbled by 437.15% to -$42.0 million in 2021.
  • The last three reported values for Other Non Operating Income were -$42.0 million (Q3 2021), -$39000.0 (Q2 2021), and $67000.0 (Q1 2021) per Business Quant data.